CREB1 and cancer: PRKG2 inhibits the migration, invasion, and proliferation of cancer cells and activates CREB, which modulates anti-apoptotic genes, such as BCL2 (Shankar et al., 2010), which are overexpressed in the resistant group, thereby contributing to the survival of cancer cells in the resistant group.